Literature DB >> 14550579

Risk factors and predictors of compliance in depression.

Koen Demyttenaere1.   

Abstract

Naturalistic studies show that the average length of antidepressant treatment is less than 6 months and that discontinuations are high, especially in primary care depressed patients. Factors leading to treatment discontinuation are multiple and poorly understood. Discontinuations are most frequent during the first month of therapy, and the prevalent reasons vary during the course of therapy. Approximately 25% of patients do not inform their physician about stopping their antidepressant medication. Recent research provides new information that may serve as a guideline for improving compliance. The physician-patient relationship, including the amount of time the physician takes to explain the expected duration of treatment and possible adverse effects, is a key factor. The physician's attitude about the medication is also important. Strategies should be adapted to the stage of treatment, as common reasons for discontinuation change as treatment progresses.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14550579     DOI: 10.1016/s0924-977x(03)00095-6

Source DB:  PubMed          Journal:  Eur Neuropsychopharmacol        ISSN: 0924-977X            Impact factor:   4.600


  22 in total

Review 1.  ACS chemical neuroscience molecule spotlight on Saredutant.

Authors:  Corey R Hopkins
Journal:  ACS Chem Neurosci       Date:  2010-10-20       Impact factor: 4.418

2.  Counseling via analogy: improving patient adherence in major depressive disorder.

Authors:  Boadie W Dunlop; Anne L Dunlop
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2005

3.  Non-adherence with psychotropic medications in the general population.

Authors:  Andrew G M Bulloch; Scott B Patten
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2009-04-04       Impact factor: 4.328

Review 4.  ACS chemical neuroscience molecule spotlight on viibryd (Vilazodone).

Authors:  Corey R Hopkins
Journal:  ACS Chem Neurosci       Date:  2011-10-19       Impact factor: 4.418

5.  Improvement in depression scores after 1 hour of light therapy treatment in patients with seasonal affective disorder.

Authors:  Gloria M Reeves; Gagan Virk Nijjar; Patricia Langenberg; Mary A Johnson; Baharak Khabazghazvini; Aamar Sleemi; Dipika Vaswani; Manana Lapidus; Partam Manalai; Muhammad Tariq; Monika Acharya; Johanna Cabassa; Soren Snitker; Teodor T Postolache
Journal:  J Nerv Ment Dis       Date:  2012-01       Impact factor: 2.254

6.  Neighbourhood Material and Social Deprivation and Exposure to Antidepressant Drug Treatment: A Cohort Study Using Administrative Data.

Authors:  Sophie Lauzier; Hichem Kadachi; Jocelyne Moisan; Alain Vanasse; Alain Lesage; Marie-Josée Fleury; Jean-Pierre Grégoire
Journal:  Can J Psychiatry       Date:  2018-03-07       Impact factor: 4.356

7.  Pharmacological and combined interventions for the acute depressive episode: focus on efficacy and tolerability.

Authors:  Andre R Brunoni; Renerio Fraguas; Felipe Fregni
Journal:  Ther Clin Risk Manag       Date:  2009-11-18       Impact factor: 2.423

8.  Explaining patients' beliefs about the necessity and harmfulness of antidepressants.

Authors:  James E Aikens; Donald E Nease; Michael S Klinkman
Journal:  Ann Fam Med       Date:  2008 Jan-Feb       Impact factor: 5.166

Review 9.  Depression Treatment Non-adherence and its Psychosocial Predictors: Differences between Young and Older Adults?

Authors:  Ifat Stein-Shvachman; Dikla Segel Karpas; Perla Werner
Journal:  Aging Dis       Date:  2013-09-20       Impact factor: 6.745

10.  Identification of primary care patients at risk of nonadherence to antidepressant treatment.

Authors:  Ann-Charlotte Akerblad; Finn Bengtsson; Margareta Holgersson; Lars von Knorring; Lisa Ekselius
Journal:  Patient Prefer Adherence       Date:  2008-02-02       Impact factor: 2.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.